Mike Irvine

Mike IRVINE is a highly experienced professional in the healthcare and life sciences industry. Mike currently holds the position of Chief Technology Officer at Verinnogen, where Mike is responsible for developing technology to enhance tumor profiling accuracy. With a Ph.D. in chemistry from The University of Manchester, Mike's expertise also includes product development, innovation, and business development. Throughout their career, Mike has held various leadership roles in companies such as Active Needle Technology Ltd., Ablatus Therapeutics, and Lightpoint Medical, showcasing their strategic vision and technical acumen. Their hands-on and reliable approach provides valuable skills and experience to drive successful outcomes in the industry.